Dunad Therapeutics
Biotechnology Research
Cambridge, United States
27 employees
- Employees
- 27
- Contacts
- 3
- Emails
- 3
Dunad Therapeutics Overview
- Headquarters
- Cambridge, United States
- Website
- www.dunadtx.com
- Industry
- Biotechnology Research
- Employees
- 27
- Founded
- 2020
- Funding
- 24.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Dunad Therapeutics
Dunad Therapeutics combines proprietary, tunable covalent chemistry with a deep understanding of disease biology to discover and develop transformational medicines that selectively and durably target disease drivers.
Dunad Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Dunad Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Ed Tate | GSK Chair in Chemical Biology |
View
|
|
| Alison Davis | Director at Dunad Therapeutics | Cambridge, Massachusetts, United States |
Email
|
| Lou Chupak | Pharmaceuticals Professional | Old Saybrook, Connecticut, United States |
Email
|
| Pearl Huang | CEO of Dunad Therapeutics | Cambridge, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to Dunad Therapeutics
Paraza Pharma Inc.
Biotechnology Research
Centessa Pharmaceuticals
Biotechnology Research
Amphista Therapeutics Limited
Biotechnology Research
Mestag Therapeutics
Biotechnology Research
Dalriada Drug Discovery
Biotechnology Research
Entact Bio
Biotechnology Research
Biotech CEO Sisterhood
Biotechnology Research
Samsara Therapeutics
Biotechnology Research
HDAX Therapeutics
Pharmaceutical Manufacturing
Noa Therapeutics
Biotechnology Research